Sugi Predict

Sugi Predict / Compounds / SCHEMBL6772157

SCHEMBL6772157

SCHEMBL6772157

Cc1ccc(-c2ccc(Cl)cc2)cc1Cn1c(C(F)F)nn(C)c1=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 3/20 0.38
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ THRB P10828 2/20 0.36
▸ GRIN2B Q13224 3/20 0.35
▸ KCNH2 Q12809 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ NOTUM Q6P988 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ GRIN1 Q05586 2/20 0.33
▸ AVPR2 P30518 2/20 0.33
▸ AVPR1A P37288 2/20 0.33
▸ NMT1 P30419 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6886472 0.91 TP53 (0.43) TP53LMNAMAPTTHRBHPGD
SCHEMBL6771980 0.90 LMNA (0.38) TP53LMNAMAPTGRIN2BHPGD
SCHEMBL6813578 0.89 TP53 (0.37) TP53LMNAMAPTTHRBGRIN2B
SCHEMBL6768769 0.89 HPGD (0.40) TP53LMNAMAPTHPGDMEN1
SCHEMBL6768635 0.85 TP53 (0.41) TP53LMNAMAPTGRIN2BHPGD
SCHEMBL6778682 0.84 GRIN1 (0.42) TP53LMNAMAPTGRIN2BHPGD
SCHEMBL6772800 0.83 TP53 (0.35) TP53LMNAMAPTHPGDMEN1
SCHEMBL6771301 0.83 MAPT (0.35) TP53LMNAMAPTHPGDMEN1
SCHEMBL6772393 0.81 GRIN1 (0.44) GRIN2BKCNH2GRIN1
SCHEMBL6774371 0.81 BRD4 (0.41) MAPTGRIN2BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040167193-A1 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-26 — — US disclosed
US-6762197-B2 FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-07-13 — — US disclosed
US-20030119670-A1 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-06-26 — — US disclosed
EP-1238975-A1 DIFLUOROMETHYLTRIAZOLONE COMPOUNDS, USE OF THE SAME AND INTERMEDIATES FOR THE PRODUCTION THEREOF Sumitomo Chemical Company, Limited (JP) 2002-09-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167193-A1 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof CYP51A1, DPM1, CYP1A1 TP53 2609/4885LMNA 3044/4885MAPT 604/4885
US-20030119670-A1 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof CYP51A1, DPM1, CYP1A1 TP53 2609/4885LMNA 3044/4885MAPT 604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.